12-45850551-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152641.4(ARID2):​c.2428G>C​(p.Ala810Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000454 in 1,614,096 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 4 hom. )

Consequence

ARID2
NM_152641.4 missense

Scores

3
16

Clinical Significance

Benign criteria provided, single submitter B:2O:1

Conservation

PhyloP100: 1.57

Publications

5 publications found
Variant links:
Genes affected
ARID2 (HGNC:18037): (AT-rich interaction domain 2) This gene encodes a member of the AT-rich interactive domain (ARID)-containing family of DNA-binding proteins. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and chromatin structure modification. This protein functions as a subunit of the polybromo- and BRG1-associated factor or PBAF (SWI/SNF-B) chromatin remodeling complex which facilitates ligand-dependent transcriptional activation by nuclear receptors. Mutations in this gene are associated with hepatocellular carcinomas. A pseudogene of this gene is found on chromosome1. [provided by RefSeq, Dec 2016]
ARID2 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
  • Coffin-Siris syndrome 6
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008124858).
BP6
Variant 12-45850551-G-C is Benign according to our data. Variant chr12-45850551-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 133566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000282 (43/152314) while in subpopulation EAS AF = 0.00579 (30/5182). AF 95% confidence interval is 0.00417. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 43 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID2NM_152641.4 linkc.2428G>C p.Ala810Pro missense_variant Exon 15 of 21 ENST00000334344.11 NP_689854.2
ARID2NM_001347839.2 linkc.2428G>C p.Ala810Pro missense_variant Exon 15 of 20 NP_001334768.1 Q68CP9
ARID2XM_047428489.1 linkc.2428G>C p.Ala810Pro missense_variant Exon 15 of 17 XP_047284445.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID2ENST00000334344.11 linkc.2428G>C p.Ala810Pro missense_variant Exon 15 of 21 1 NM_152641.4 ENSP00000335044.6 Q68CP9-1

Frequencies

GnomAD3 genomes
AF:
0.000283
AC:
43
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00578
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000414
AC:
104
AN:
250938
AF XY:
0.000376
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00496
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000981
GnomAD4 exome
AF:
0.000472
AC:
690
AN:
1461782
Hom.:
4
Cov.:
32
AF XY:
0.000461
AC XY:
335
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33472
American (AMR)
AF:
0.0000224
AC:
1
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0148
AC:
589
AN:
39690
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111966
Other (OTH)
AF:
0.00144
AC:
87
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000282
AC:
43
AN:
152314
Hom.:
0
Cov.:
32
AF XY:
0.000336
AC XY:
25
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41568
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00579
AC:
30
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68036
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000293
Hom.:
0
Bravo
AF:
0.000264
ExAC
AF:
0.000362
AC:
44
Asia WGS
AF:
0.00635
AC:
22
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

ARID2-related disorder Benign:1
Feb 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Dec 10, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.014
T;T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.75
T;.;T
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.0081
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.81
L;.;.
PhyloP100
1.6
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.080
N;N;N
REVEL
Benign
0.031
Sift
Uncertain
0.0050
D;D;D
Sift4G
Benign
0.13
T;T;T
Polyphen
0.0020
B;.;B
Vest4
0.23
MVP
0.20
MPC
0.16
ClinPred
0.028
T
GERP RS
4.0
Varity_R
0.13
gMVP
0.26
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74916892; hg19: chr12-46244334; COSMIC: COSV57615592; API